Shokooh Salimimoghadam

2.1k total citations
49 papers, 1.4k citations indexed

About

Shokooh Salimimoghadam is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shokooh Salimimoghadam has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 30 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Shokooh Salimimoghadam's work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers) and Circular RNAs in diseases (17 papers). Shokooh Salimimoghadam is often cited by papers focused on MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers) and Circular RNAs in diseases (17 papers). Shokooh Salimimoghadam collaborates with scholars based in Iran, United States and Canada. Shokooh Salimimoghadam's co-authors include Afshin Taheriazam, Mehrdad Hashemi, Maliheh Entezari, Kiavash Hushmandi, Mohsen Rashidi, Amirabbas Kakavand, Saeed Samarghandian, Sepideh Mirzaei, Sima Orouei and Mohammad Arad Zandieh and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Shokooh Salimimoghadam

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shokooh Salimimoghadam Iran 22 863 545 258 193 118 49 1.4k
Xupeng Bai China 15 874 1.0× 426 0.8× 386 1.5× 180 0.9× 88 0.7× 25 1.4k
Wanyeon Kim South Korea 24 977 1.1× 602 1.1× 341 1.3× 228 1.2× 86 0.7× 45 1.6k
Yubo Tang China 20 1.0k 1.2× 606 1.1× 314 1.2× 174 0.9× 73 0.6× 49 1.6k
Zhiwei He China 24 1.1k 1.3× 729 1.3× 352 1.4× 165 0.9× 125 1.1× 89 1.8k
Peng Bai China 24 972 1.1× 380 0.7× 192 0.7× 92 0.5× 108 0.9× 69 1.5k
Călin Ionescu Romania 14 814 0.9× 447 0.8× 265 1.0× 126 0.7× 70 0.6× 20 1.3k
Chuangye Han China 24 790 0.9× 644 1.2× 318 1.2× 407 2.1× 196 1.7× 89 1.5k
Zhinong Jiang China 21 892 1.0× 425 0.8× 337 1.3× 147 0.8× 105 0.9× 71 1.6k
Yahui Ding China 23 976 1.1× 506 0.9× 247 1.0× 295 1.5× 99 0.8× 87 1.8k
Amir Reza Aref United States 25 1.4k 1.6× 914 1.7× 309 1.2× 191 1.0× 130 1.1× 50 2.0k

Countries citing papers authored by Shokooh Salimimoghadam

Since Specialization
Citations

This map shows the geographic impact of Shokooh Salimimoghadam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shokooh Salimimoghadam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shokooh Salimimoghadam more than expected).

Fields of papers citing papers by Shokooh Salimimoghadam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shokooh Salimimoghadam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shokooh Salimimoghadam. The network helps show where Shokooh Salimimoghadam may publish in the future.

Co-authorship network of co-authors of Shokooh Salimimoghadam

This figure shows the co-authorship network connecting the top 25 collaborators of Shokooh Salimimoghadam. A scholar is included among the top collaborators of Shokooh Salimimoghadam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shokooh Salimimoghadam. Shokooh Salimimoghadam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hushmandi, Kiavash, Najma Farahani, Behzad Einollahi, et al.. (2025). Deciphering molecular pathways in urological cancers: A gateway to precision therapeutics. Journal of Advanced Research. 81. 967–1003. 4 indexed citations
2.
Hushmandi, Kiavash, Behzad Einollahi, Antonino Glaviano, et al.. (2025). Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence. International Journal of Biological Sciences. 21(4). 1410–1435. 5 indexed citations
3.
Koohpar, Zeinab Khazaei, Ali Moghadas Jafari, Shokooh Salimimoghadam, et al.. (2024). Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies. Translational Oncology. 50. 102145–102145. 1 indexed citations
4.
Hushmandi, Kiavash, Daniel J. Klionsky, Amir Reza Aref, et al.. (2024). Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications. Non-coding RNA Research. 9(4). 1159–1177. 10 indexed citations
5.
Rezaee, Aryan, Romina Rajabi, Ramin Khorrami, et al.. (2023). PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation. European Journal of Pharmacology. 955. 175909–175909. 13 indexed citations
6.
Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.. (2023). miRNAs as short non-coding RNAs in regulating doxorubicin resistance. Journal of Cell Communication and Signaling. 17(4). 1181–1202. 2 indexed citations
7.
Sadrkhanloo, Mehrdokht, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.. (2023). STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomedicine & Pharmacotherapy. 158. 114168–114168. 35 indexed citations
8.
Hashemi, Mehrdad, Romina Rajabi, Parham Rahmanian, et al.. (2023). Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions. Biomedicine & Pharmacotherapy. 158. 114204–114204. 75 indexed citations
9.
Rahmanian, Parham, Mohammad Arad Zandieh, Noushin Nabavi, et al.. (2023). Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine development. Environmental Research. 237(Pt 2). 117027–117027. 23 indexed citations
10.
Entezari, Maliheh, Ali Jebali, Ramin Khorrami, et al.. (2023). Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers. Environmental Research. 225. 115673–115673. 21 indexed citations
11.
Rezaee, Aryan, Mohammad Arad Zandieh, Noushin Nabavi, et al.. (2023). Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application. International Journal of Biological Macromolecules. 242(Pt 3). 124935–124935. 14 indexed citations
12.
Zandieh, Mohammad Arad, Parham Rahmanian, Aryan Rezaee, et al.. (2023). Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy. Translational Oncology. 39. 101838–101838. 8 indexed citations
13.
Kakavand, Amirabbas, Mohammad Ali Sheikh Beig Goharrizi, Amir Reza Aref, et al.. (2023). Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks. International Journal of Biological Macromolecules. 232. 123377–123377. 31 indexed citations
14.
Mirzaei, Sepideh, Mehrdad Hashemi, Amir Reza Aref, et al.. (2023). Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways. Biomedicine & Pharmacotherapy. 160. 114395–114395. 47 indexed citations
15.
Hashemi, Mehrdad, Romina Rajabi, Zeinab Khazaei Koohpar, et al.. (2023). Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. Cell Communication and Signaling. 21(1). 32–32. 32 indexed citations
16.
Sadrkhanloo, Mehrdokht, Maliheh Entezari, Sima Orouei, et al.. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research. 182. 106311–106311. 114 indexed citations
17.
Entezari, Maliheh, Afshin Taheriazam, Sima Orouei, et al.. (2022). LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy. 154. 113609–113609. 61 indexed citations
18.
Hashemi, Mehrdad, Amirabbas Kakavand, Alireza Tavakolpournegari, et al.. (2022). Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance. International Journal of Biological Macromolecules. 222(Pt A). 1151–1167. 20 indexed citations
19.
Hashemi, Mehrdad, Sepideh Mirzaei, Elahe Sadat Hejazi, et al.. (2022). Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects. Life Sciences. 309. 120984–120984. 27 indexed citations
20.
Hashemi, Mehrdad, Sepideh Mirzaei, Mohammad Arad Zandieh, et al.. (2022). Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology. 177. 207–228. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xupeng Bai Breakdown of academic impact, for papers by Wanyeon Kim Breakdown of academic impact, for papers by Yubo Tang Breakdown of academic impact, for papers by Zhiwei He Breakdown of academic impact, for papers by Peng Bai Breakdown of academic impact, for papers by Călin Ionescu Breakdown of academic impact, for papers by Chuangye Han Breakdown of academic impact, for papers by Zhinong Jiang Breakdown of academic impact, for papers by Yahui Ding Breakdown of academic impact, for papers by Amir Reza Aref
Rankless by CCL
2026